{
    "Trade/Device Name(s)": [
        "Steripath Gen2 Blood Collection System"
    ],
    "Submitter Information": "Magnolia Medical Technologies, Inc.",
    "510(k) Number": "K192247",
    "Predicate Device Reference 510(k) Number(s)": [
        "K030573",
        "K081229",
        "K991088",
        "K980987"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKA",
        "FPA"
    ],
    "Summary Letter Date": "February 28, 2020",
    "Summary Letter Received Date": "January 28, 2020",
    "Submission Date": "January 28, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Specimen diversion",
        "Mechanical blood collection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Steripath Gen2 Blood Collection System, a device for blood specimen diversion and collection to reduce blood culture contamination.",
    "Indications for Use Summary": "For in vitro diagnostic blood collection; diverts and sequesters initial specimen to reduce blood culture contamination, with components usable for short-term infusion after sample collection.",
    "fda_folder": "Clinical Chemistry"
}